ACR Updates: COVID-19


Breaking News

ACR COVID-19 Clinical Guidance Town Hall

On May 6, the ACR hosted a virtual town hall to discuss the recently published COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases. Panelists and moderators discussed the guidance recommendations and answered a number of questions submitted by attendees. Watch the complete event   


 HHS Announces Additional Allocations to Relief Fund

The Department of Health and Human Services (HHS) has announced details on remaining allocations of the Provider Relief Fund created by the CARES Act. An additional $20 billion has been designated for general distribution to Medicare facilities and providers impacted by COVID-19. Unlike the initial tranche of funding from the HHS, most eligible practices will need to complete the application before funds are approved and sent to their bank account. HHS Announces Additional Allocations to Relief Fund


 COVID-19 CARES Act Package Additional Funds Summary

On April 21, the Senate passed legislation injecting additional funds in the CARES Act. The House is predicted to vote to pass the package on April 23. Read more about what was included in the package, and ask Congress to preserve patient access by supporting provider solvency.


See All Breaking News


In response to the recently published COVID-19 Clinical Guidance for Adult Patients with Rheumatic Diseases, the ACR hosted a virtual town hall on May 6 for the rheumatology community to review the recommendations. ACR President Ellen Gravallese, MD, and ACR Secretary, Kenneth Saag, MD, MSc, served as co-moderators for the discussion.

Ted Mikuls, MD, MSPH
Bonnie Bermas, MD
Stanley Cohen, MD, MACR
Karen Costenbader, MD, MPH
Michael Weinblatt, MD, MACR
Kevin Winthrop, MD, MPH


Practice and Advocacy Resources

ACR COVID-19 practice and advocacy resourcesThe ACR’s COVID-19 Practice and Advocacy Task Force continues to work rapidly to provide support to you during this unprecedented time. You’ll find guidance documents that include approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, and guidance for infusions. Working with experts in COVID-related topics, we are focused on developing meaningful information and resources to help guide you.

Practice and Advocacy Resources

COVID-19 Manufacturer Resources and Patient Assistance Programs  - New


Clinical Guidance for Adult Patients with Rheumatic Diseases

ACR COVID-19 clinical guidance for patients with rheumatic diseasesThe ACR has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.



COVID-19 Clinical Guidance Summary  - Updated April  30, 2020

ACR Guidance for Management of Adult Patients with Rheumatic Disease During COVID‐19 (paper)  - Published April 29, 2020

How to cite this article: Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheumatol doi: E-pub ahead of print.

You can also access the clinical guidance information on your iOS or Android mobile device. Download the free ACR Guideline and Criteria App on the App Store or Google Play.


Global Rheumatology Alliance

COVID-19 Global Rheumatology AllianceThe COVID-19 Global Rheumatology Alliance, a section of the American College of Rheumatology, is a provider-entered registry aiming to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.

The Global Rheumatology Community’s Response to the Worldwide COVID-19 Pandemic  

Help Us Help Patients: Report a COVID-19 Case  


COVID-19: The Rheumatologist

COVID-19: Wiley Journal Articles

Mental Health & Well-being Resources

ACR Meetings and Program Updates



Experiencing COVID-19 related drug shortages, practice issues, or any other problems?
Share your comments and questions with us at

Updated May 20, 2020 at 9:45 AM ET

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us